NEWS

Latest News

April 28, 2026
Biotech Leadership Conversations
Carmen Caricchio, CEO & Founder, RareSight
Author: Steve Ruddy
[READ MORE]

February 10, 2026
Drug Discovery News
Sustained-release drug delivery targets pediatric inherited retinal disease
Author: Andrea Corona
[READ MORE]

November 19, 2025
The Almanac
Entrepreneur Pushes for New Treatments for Childhood Eye Diseases
Author: Arden Margulis
[READ MORE]

November 14, 2025
Market Scope
PolyActiva, RareSight to Collaborate on Rare Pediatric Retinal Diseases
Author: Jennie Crabbe
[READ MORE]

Nov 12, 2025
Eyes On Eyecare Glance
PolyActiva and RareSight to advance long-acting therapies for pediatric IRDs
Author: Alex Delaney-Gesing
[READ MORE]

November 7, 2025
Ophthalmology Times
PolyActiva and RareSight Partner to Develop Treatments for Rare Pediatric Retinal Diseases
Author: Martin David Harp
[READ MORE]

November 7, 2025
PIE Magazine
PolyActiva and RareSight Join Forces to Target Rare Pediatric Retinal Diseases
Author: Marhiel Garrote
[READ MORE]

November 6, 2025
Global Genes (Rare Daily)
PolyActiva and RareSight Form Rare Pediatric Retinal Diseases Strategic Collaboration
[READ MORE]

November 6, 2025
Eyewire+
PolyActiva and RareSight Announce Strategic Collaboration for Pediatric Retinal Diseases
[READ MORE] 

November 6, 2025
The Pharma Letter
PolyActiva and RareSight Join Forces to Target Childhood Retinal Diseases
[READ MORE]

November 6, 2025
BioSpace
PolyActiva and RareSight Form Strategic Collaboration to Develop Breakthrough Treatments for Rare Pediatric Retinal Diseases
[READ MORE]

November 5, 2025
BioWorld
Other News to Note for Nov. 5, 2025
[READ MORE]

November 5, 2025
Contract Pharma
PolyActiva, RareSight Partner to Develop Therapies for Rare Pediatric Retinal Diseases
Author: Charlie Sternberg
[READ MORE]